Literature DB >> 8392592

A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain.

L P Perera1, J D Mosca, W T Ruyechan, G S Hayward, S E Straus, J Hay.   

Abstract

Accumulating evidence indicates that the product of the putative immediate-early gene ORF62 (IE62) activates varicella-zoster virus (VZV) genes thought to represent all three kinetic classes, namely, immediate-early (alpha), early (beta), and late (gamma) classes, of VZV genes as well as a variety heterologous gene promoters. However, the mechanism(s) by which IE62 protein mediates transactivation of these diverse VZV and heterologous gene promoters remains to be elucidated. In this study, by using yeast GAL4 protein chimeras, the coding regions of VZV ORF62 possessing activation domains have been assessed. We demonstrate that the VZV IE62 protein contains a potent activation domain in the N-terminal portion of the molecule, encoded within the first 86 codons of ORF62. The predicted secondary structure profile and the acid-base composition of this IE62 domain resemble those of other transregulatory proteins whose activation is mediated through acidic, hydrophobic elements. In addition, we show that deletion of this activation domain from the 1,310-residue native IE62 protein results in ablation of the transactivator function of IE62. We also present evidence that the mutant IE62 protein lacking the activation domain, though devoid of transactivation ability, was still capable of interfering with the activation of target promoters by the native, full-length IE62.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392592      PMCID: PMC237830     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

2.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

3.  GAL4 derivatives function alone and synergistically with mammalian activators in vitro.

Authors:  Y S Lin; M F Carey; M Ptashne; M R Green
Journal:  Cell       Date:  1988-08-26       Impact factor: 41.582

Review 4.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

5.  Nucleosome loss activates yeast downstream promoters in vivo.

Authors:  M Han; M Grunstein
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

Review 6.  A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae.

Authors:  M Johnston
Journal:  Microbiol Rev       Date:  1987-12

7.  The immediate early proteins of varicella-zoster virus.

Authors:  K Shiraki; R W Hyman
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

8.  Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants.

Authors:  J M Felser; S E Straus; J M Ostrove
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

9.  Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1.

Authors:  J M Felser; P R Kinchington; G Inchauspe; S E Straus; J M Ostrove
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

Review 10.  The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; M A Dalrymple; A J Davison; A Dolan; M C Frame; D McNab; L J Perry; J E Scott; P Taylor
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

View more
  47 in total

1.  Identification of a motif in the C terminus of herpes simplex virus regulatory protein ICP4 that contributes to activation of transcription.

Authors:  James W Bruce; Kent W Wilcox
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein.

Authors:  Mohamed I Khalil; Ann Arvin; Jeremy Jones; William T Ruyechan
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 4.  Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model.

Authors:  Chia-Chi Ku; Jaya Besser; Allison Abendroth; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase.

Authors:  Amie J Eisfeld; Stephanie E Turse; Sara A Jackson; Edwina C Lerner; Paul R Kinchington
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Repression of TFII-I-dependent transcription by nuclear exclusion.

Authors:  M I Tussié-Luna; D Bayarsaihan; F H Ruddle; A L Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 7.  Integrase, LEDGF/p75 and HIV replication.

Authors:  E M Poeschla
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

8.  Analysis of the varicella-zoster virus IE62 N-terminal acidic transactivating domain and its interaction with the human mediator complex.

Authors:  Shinobu Yamamoto; Alexander Eletsky; Thomas Szyperski; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

9.  The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator.

Authors:  Cristian Cilloniz; Wallen Jackson; Charles Grose; Donna Czechowski; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Mutational analysis of varicella-zoster virus major immediate-early protein IE62.

Authors:  L Baudoux; P Defechereux; S Schoonbroodt; M P Merville; B Rentier; J Piette
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.